Parallel-group study comparing the effect of treatment in diabetes between insulin glargin U-300 (Lantus XR) and insulin glargin biosimillar (Insulin Glargin BS milliopen "Lily") in patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000031415
- Lead Sponsor
- ihon University Itabashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criterias are shown as follows; 1.Patients who are a possibility of pregnancy or pregnant. 2.Patients with severe ketosis, diabetic coma or pre coma. 3.Patents with severe infections, before and after surgery or serious traumatic injury. 4.Patients undergoing blood purification therapy. 5.Patients using implantable medical devices such as pacemakers. 6.Patients receiving steroid drugs. 7.Patients with dementia. 8.Patients who are judged as inappropriae for this study by reserchers . 9.Patients who refuse to be enrolled in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method